CHCWM – Cancer & Hematology Centers of West Michigan

SM08502-ONC-01 (Samumed, LLC)

A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 In Subjects with Advanced Solid Tumors